Researchers Develop Mucus-Based Bioink for 3D Printing Lung Tissue

This innovative bioink could revolutionize the study and treatment of chronic lung diseases by offering a more accurate model for human lung tissue.

Millions die annually from lung diseases, with limited treatment options and inadequate animal models for research.
The bioink, made from mucin and hyaluronic acid, supports cell growth and mimics human lung tissue.
Printed structures are stable, nontoxic, and biodegradable, potentially useful for implants and disease modeling.
The bioink's porous gel structure allows for nutrient and oxygen diffusion, promoting lung tissue formation.
This development could lead to better study models and new treatments for chronic conditions like COPD and cystic fibrosis.